McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook
McKesson shares slipped 0.1% to $956.71 in early New York trading Friday after a 16.5% surge the previous session. The company raised its fiscal 2026 adjusted earnings guidance to $38.80-$39.20 per share and confirmed plans to spin off its medical-surgical unit with an IPO targeted for late 2027. Fiscal Q3 revenue rose 11% to $106.2 billion.